Home/Filings/4/0001013762-25-004101
4//SEC Filing

Zummo Jacqueline 4

Accession 0001013762-25-004101

CIK 0001359931other

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 4:12 PM ET

Size

5.6 KB

Accession

0001013762-25-004101

Insider Transaction Report

Form 4
Period: 2025-03-26
Zummo Jacqueline
Chf Scientific Operations Off
Transactions
  • Sale

    Common Stock

    2025-03-26$4.53/sh21,224$96,14598,861 total
Footnotes (2)
  • [F1]The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 23, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.41 to $4.69, inclusive. The reporting person undertakes to provide to TARA, any security holder of TARA, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Issuer

Protara Therapeutics, Inc.

CIK 0001359931

Entity typeother

Related Parties

1
  • filerCIK 0001798929

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 4:12 PM ET
Size
5.6 KB